论文信息 - A randomized, double-blind phase III study of pazopanib in treatment-naive and cytokine-pretreated patients with advanced renal cell carcinoma (RCC). - 字舞流文

A randomized, double-blind phase III study of pazopanib in treatment-naive and cytokine-pretreated patients with advanced renal cell carcinoma (RCC).

C. Sternberg | I. Davis | C. Szczylik | J. Mardiak | R. Hawkins | P. Salman | L. Pandite | R. Hawkins | E. Lee | Eunsik Lee | Mei Chen | L. Mccann | M. Chen | M. Chen | L. McCann | E. Lee